Protica obtains exclusive distribution rights for aseptic dispensing device

NewsGuard 100/100 Score

Protica, Inc., the makers of the first protein shot, Profect®, and dozens of the world’s most compact protein and energy drinks, has now set its sights on bulk packaging, thanks to International Dispensing Corporation’s (IDC) (IDND.PK) patented aseptic tap The Answer™.

The Answer, the world’s only aseptic dispensing device, enables shelf-stable liquids in large-format packages – such as a bag-in-box – to be dispensed safely and repeatedly over extended time without refrigeration. IDC and Protica recently inked a deal that grants Protica exclusive distribution rights to The Answer for protein-based and energy-based liquids.

“The Answer allows consumers to purchase many of the same beverages and liquid supplements they have bought in the past, but in a bulk format that requires no refrigeration and gives the consumer a tremendous cost savings at the register,” says Greg Abbott, founder and chairman of IDC. “It enables the consumer to store the product virtually anywhere, even after repeated use, and is extremely environmentally-friendly, cutting down on landfill waste and reducing greenhouse gas emissions.”

“For several years Protica has been the exclusive manufacture of vial-based protein and energy drinks, producing some of the most compact beverages and supplements on the market,” says Jim Duffy, Protica president. “One of the drivers for us has been to deliver novel, efficacious products with the greatest level of convenience. The Answer allows us to continue that movement, but on a bulk basis. We can now deliver a tremendous economy of scale to our business partners and consumers.”

Protica’s house brands and private-labeled brands are currently distributed in tens of thousands of retail locations throughout the healthcare, sports nutrition and mass retail channels. Products using The Answer will be sold through the same channels.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Intracellular protein delivery with HyNT stamp system: A leap forward in cancer therapy